Neurocrine Biosciences (NBIX) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026)
Neurocrine Biosciences (NBIX) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | -11.41% |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 8.48% |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 27.10% |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | -7.49% |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 13.12% |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 11.74% |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -11.76% |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 7.32% |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Liquidia | 5.74 Bn | 5.52 Bn | 121.79 Mn | 68.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.12% |
| Dec 31, 2025 | 15.29% |
| Sep 30, 2025 | 16.90% |
| Jun 30, 2025 | 11.14% |
| Mar 31, 2025 | 10.83% |
| Dec 31, 2024 | 12.12% |
| Sep 30, 2024 | 16.12% |
| Jun 30, 2024 | 17.01% |
| Mar 31, 2024 | 18.46% |
| Dec 31, 2023 | 16.65% |
| Sep 30, 2023 | 16.96% |
| Jun 30, 2023 | 13.73% |
| Mar 31, 2023 | 14.44% |
| Dec 31, 2022 | 11.83% |
| Sep 30, 2022 | 14.75% |
| Jun 30, 2022 | 19.02% |
| Mar 31, 2022 | 20.35% |
| Dec 31, 2021 | 20.05% |
| Sep 30, 2021 | 21.32% |
| Jun 30, 2021 | 38.61% |